Black Diamond 2
Pharma & Biotech company headquartered in Cambridge, MA. Cross-border supply chain, facility locations, and freight intelligence below.
Black Diamond Therapeutics BDTX-4933 allosteric EGFR inhibitor for lung cancer.
- Industry
- Pharma & Biotech
- Headquarters
- Cambridge, MA
- Revenue
- revenue of $70.0M
- US facilities
- Cambridge, MA
Start a free trial to see Black Diamond 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.